Company / Operating Cash Flow per Share
Kiniksa Pharmaceuticals International, plc Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.92
FY2025
5-year range
-$2.93 / $1.92
FY2021-FY2025
Trend
+425.9%
vs FY2024
Sector context
#43 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +426% YoY in FY2025, a notable deviation from the 8-year average annual change of +100%.
Based on SEC 10-K filings.
1.92 in FY2025 with a 3-year CAGR of +173.4%. Top quartile in the Health Care sector.
Improved from $0.19 to $1.92 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +173.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 212This company $1.92 Sector average $5.28
▼
-63.6% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 425.9% year-over-year.
- Ranks #43 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.92 | +425.9% |
| FY2024 | $0.36 | +88.1% |
| FY2023 | $0.19 | +106.6% |
| FY2022 | $0.09 | +103.2% |
| FY2021 | -$2.93 | -32.7% |
| FY2020 | -$2.21 | +24.7% |
| FY2019 | -$2.93 | -6.9% |
| FY2018 | -$2.74 | +90.1% |
| FY2017 | -$27.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026